BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6410641)

  • 21. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
    Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphometric and related quantitative techniques in the study of lymphoid neoplasms. A review.
    Crocker J
    J Pathol; 1984 Jun; 143(2):69-80. PubMed ID: 6376742
    [No Abstract]   [Full Text] [Related]  

  • 23. Interdigitating reticulum cells in the dermal infiltrate of mycosis fungoides. An ultrastructural and immunohistochemical study.
    Bani D; Moretti S; Pimpinelli N; Giannotti B
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(5):451-8. PubMed ID: 3128914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of surface markers and cytoplasmic organelle in benign and malignant lymphoid lesions of skin; immunohistochemical and electron microscopic evaluation.
    Jimbow K; Katoh M; Nishio C; Jimbow M
    J Cutan Pathol; 1981 Aug; 8(4):283-98. PubMed ID: 7309942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
    Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycosis fungoides: clinical course and cellular abnormalities.
    Epstein EH
    J Invest Dermatol; 1980 Jul; 75(1):103-6. PubMed ID: 6993579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dohi memorial lecture. Cutaneous T cell lymphoma.
    Edelson RL
    J Dermatol; 1987 Oct; 14(5):397-410. PubMed ID: 2893818
    [No Abstract]   [Full Text] [Related]  

  • 28. IgG anti-50 kd lymphocyte membrane peptide antibody in patients with Sézary syndrome.
    D'Ambra-Cabry K; Tharp MD; Jagasothy BV; Deng JS
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):777-80. PubMed ID: 8632073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.
    Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP
    Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous T-cell lymphoma in association with a monoclonal gammopathy.
    Joyner MV; Cassuto JP; Dujardin P; Barety M; Duplay H; Audoly P
    Arch Dermatol; 1979 Mar; 115(3):326-8. PubMed ID: 107864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoma and leukemia of t-lymphocytes.
    Watanabe S; Shimosato Y; Shimoyama M
    Pathol Annu; 1981; 16(Pt 2):155-203. PubMed ID: 7036059
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cutaneous malignant lymphomas].
    Ben Romdhane K
    Tunis Med; 1989; 67(6-7):385-90. PubMed ID: 2678641
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
    Dmitrovsky E; Matthews MJ; Bunn PA; Schechter GP; Makuch RW; Winkler CF; Eddy J; Sausville EA; Ihde DC
    J Clin Oncol; 1987 Feb; 5(2):208-15. PubMed ID: 3492594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
    Lange Wantzin G; Saxinger WC; Woods A; Larsen JK; Thomsen K; Gallo RC
    Acta Derm Venereol; 1984; 64(5):395-9. PubMed ID: 6208717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome.
    Wada DA; Wilcox RA; Harrington SM; Kwon ED; Ansell SM; Comfere NI
    Am J Hematol; 2011 Mar; 86(3):325-7. PubMed ID: 21328438
    [No Abstract]   [Full Text] [Related]  

  • 39. Differentiation of interdigitating reticulum cells and Langerhans cells in the human skin with T-lymphoid infiltrate. An immunocytochemical and ultrastructural study.
    Bani D; Giannotti B
    Arch Histol Cytol; 1989 Oct; 52(4):361-72. PubMed ID: 2513848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.